Skip to main content
A

AimingMed

The startup develops precision oncology solutions using tumor organoids for drug screening and evaluation model construction. This technology enables medical enterprises to accelerate drug research and development while significantly reducing associated costs.

Founded 2020910+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Features

  • The startup develops precision oncology solutions using tumor organoids for drug screening and evaluation model construction. This technology enables medical enterprises to accelerate drug research and development while significantly reducing associated costs.
This profile is AI-generated and may contain inaccuracies.